MIFClass II
Prothrombin Fragment 1.2
21 CFR 864.7320 / Hematology
MIF is the FDA product code for Prothrombin Fragment 1.2, a class II device type, regulated under 21 CFR 864.7320. As of , FDA records hold 6 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- MIF
- Device name
- Prothrombin Fragment 1.2
- Regulation
- 21 CFR 864.7320
- Device class
- Class II
- Review panel
- Hematology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- Yes
- Ingested clearances
- 6
- Ingested recalls
- 0
Clearances, product code MIF
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1991 | 1 |
| 1992 | 2 |
| 1996 | 1 |
| 1997 | 1 |
| 2004 | 1 |
Applicants with the most clearances
Product code MIF| Applicant | Clearances |
|---|---|
| bioMerieux, Inc. | 2 |
| Baxter Diagnostics, Inc. | 1 |
| Behring Diagnostics, Inc. | 1 |
| Siemens Healthcare Diagnostics Inc. | 1 |
| Panbio Limited | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
